Derakhshan, Mohammad H.Dean, LindaJones, Gareth T.Siebert, StefanGaffney, Karl2020-12-152020-12-152020-07-08Derakhshan, M H, Dean, L, Jones, G T, Siebert, S & Gaffney, K 2020, 'Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns : Results from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis', RMD Open, vol. 6, no. 2, e001206, pp. 1-7. https://doi.org/10.1136/rmdopen-2020-0012062056-5933ORCID: 0000-0003-0016-7591ORCID: 0000-0002-2549-7100ORCID: 0000-0001-7667-5352ORCID: 0000-0002-1802-7311ORCID: 0000-0002-7863-9176ORCID: /0000-0003-0016-7591/work/86449683https://hdl.handle.net/2164/15514Funding This work was supported by the British Society for Rheumatology (BSR) who have funded the BSRBR-AS. The BSR received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments but have no input into the topics for analysis in the register nor the work involved in undertaking analysis. Original analysis of data was supported by the Versus Arthritis/Medical Research Council Centre for Musculoskeletal Health and Work (grant number 20665). The current analyses were funded by the British Society of Spondyloarthritis (BritSpA). Contributors Study concept and design: MHD, SS, KG. Analysis and interpretation of data: all authors. Drafting the manuscript: MHD, SS, KG. Critical revision of the manuscript for important intellectual content: all authors. Competing interests GTJ reports grants from AbbVie, Pfizer and UCB during the conduct of the study; grants from Amgen and GlaxoSmithKline, outside the submitted work. SS has received research grants, speaker or consultancy fees from AbbVie, Amgen (previously Celgene), BMS, Boehringer-Ingelheim, GlaxoSmithKline, Janssen, Novartis, Pfizer and UCB. KG has received research grants, speaker or consultancy fees from AbbVie, Celgene, Biogen, MSD, Novartis, Pfizer and UCB Pharma. Other authors have no relevant interests to declare.7478875engSDG 3 - Good Health and Well-beingAnti-TNFEpidemiologySpondyloarthritisR MedicineImmunology and AllergyRheumatologyImmunologyMedical Research Council (MRC)RJournal article10.1136/rmdopen-2020-001206http://www.scopus.com/inward/record.url?scp=85087680162&partnerID=8YFLogxK